Author
Listed:
- Christina Heinemann
(Klinikum rechts der Isar, Technische Universität München)
- Sylvia Heink
(Klinikum rechts der Isar, Technische Universität München)
- Franziska Petermann
(Klinikum rechts der Isar, Technische Universität München)
- Ajithkumar Vasanthakumar
(The Walter and Eliza Hall Institute of Medical Research
The University of Melbourne)
- Veit Rothhammer
(Klinikum rechts der Isar, Technische Universität München)
- Elien Doorduijn
(The Walter and Eliza Hall Institute of Medical Research
The University of Melbourne)
- Meike Mitsdoerffer
(Klinikum rechts der Isar, Technische Universität München)
- Christopher Sie
(Klinikum rechts der Isar, Technische Universität München)
- Olivia Prazeres da Costa
(Institute for Medical Microbiology, Immunology, and Hygiene, Technische Universität München)
- Thorsten Buch
(Institute for Medical Microbiology, Immunology, and Hygiene, Technische Universität München)
- Bernhard Hemmer
(Klinikum rechts der Isar, Technische Universität München
Munich Cluster for Systems Neurology (SyNergy))
- Mohamed Oukka
(Seattle Children’s Hospital, Center for Immunity and Immunotherapies, University of Washington School of Medicine)
- Axel Kallies
(The Walter and Eliza Hall Institute of Medical Research
The University of Melbourne)
- Thomas Korn
(Klinikum rechts der Isar, Technische Universität München
Munich Cluster for Systems Neurology (SyNergy))
Abstract
Central nervous system (CNS) autoimmunity is regulated by the balance of pro-inflammatory cytokines and IL-10. Here we identify the transcriptional regulator Blimp1 as crucial to induce IL-10 in inflammatory T helper cells. Pre-committed Th17 cells respond to IL-27 and IL-12 by upregulating Blimp1 and adopt a Tr-1-like phenotype characterized by IL-10 and IFN-γ production. Accordingly, Blimp1-deficient effector T cells fail to produce IL-10, and deficiency in Tr-1 cell function leads to uncontrolled Th17 cell-driven CNS pathology without the need to stabilize the Th17 phenotype with IL-23. IL-23 counteracts IL-27 and IL-12-mediated effects on Tr-1-development reinforcing the pro-inflammatory phenotype of Th17 cells. Thus, the balance of IL-23 vs IL-12/IL-27 signals into CD4+ effector T cells determines whether tissue inflammation is perpetuated or resolves.
Suggested Citation
Christina Heinemann & Sylvia Heink & Franziska Petermann & Ajithkumar Vasanthakumar & Veit Rothhammer & Elien Doorduijn & Meike Mitsdoerffer & Christopher Sie & Olivia Prazeres da Costa & Thorsten Buc, 2014.
"IL-27 and IL-12 oppose pro-inflammatory IL-23 in CD4+ T cells by inducing Blimp1,"
Nature Communications, Nature, vol. 5(1), pages 1-13, September.
Handle:
RePEc:nat:natcom:v:5:y:2014:i:1:d:10.1038_ncomms4770
DOI: 10.1038/ncomms4770
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:5:y:2014:i:1:d:10.1038_ncomms4770. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.